Sinovac Biotech Ltd.’s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other…
from NDTV News – Topstories https://ift.tt/3d5VAV8
via IFTTT
